Signum Biosciences develops small molecule therapeutics derived from its STM platform to modulate signal transduction imbalances.

Biotechnology

Life Sciences

Therapeutics

Signum Biosciences

Signum Biosciences' headquarters in Boulder, CO, United States

Maxwell Stock

Lisa Johnson

Viken Arslanian

Jose Fernandez

Michael J. Losch

Masanori (Markie) Tamura

Jeffry Stock

The Research & Development team at Signum Biosciences focuses on discovering and developing small molecule therapeutics using the STM platform to correct signal transduction imbalances. They conduct cutting-edge scientific research and oversee the development of innovative products from initial concept through to clinical trials.

Research & Development

The Leadership Team at Signum Biosciences is responsible for shaping the strategic direction of the company, guiding its research and development initiatives, and driving commercial growth. This team, composed of experienced executives in scientific and business domains, ensures alignment between innovation and market needs while fostering collaboration and mentorship across all levels of the organization. Through their combined expertise, they aim to advance the development of small molecule therapeutics that address signal transduction imbalances.

Signum Biosciences

Org chart

Board & advisors

Teams

Research & Development

Leadership Team

Offices

Signum Biosciences

Org chart

Board & advisors

Teams

Research & Development

Leadership Team

Offices

Related companies